采用慢病毒载体干扰TRAF2表达的MH7A细胞稳转株的构建及意义OACSTPCD
Significance and successful construction of stable transfection of MH7A cells with lower TRAF2 expression using lentiviral vector
目的 用慢病毒载体构建干扰肿瘤坏死因子受体相关因子2(TRAF2)表达的类风湿关节炎(RA)患者滑膜细胞株MH7A细胞稳转株,研究TNF-α-TRAF2信号在MH7A异常增殖的作用.方法 根据人TRAF2的基因序列和shRNA序列设计原则,设计并合成3对TRAF2-shRNA干扰序列,通过PCR对引物进行退火,通过双酶切PLKO.1-puro获得线性载体,将线性化载体与退火后引物通过Solution I连接,连接产物导入感受态细胞,涂板,挑取阳性菌落进行测序.构建3种不同的PLKO.1-TRAF2-shRNA慢病毒重组质粒,借助慢病毒包装质粒对对数生长期的HEK 293T细胞进行慢病毒包装,收集病毒液感染MH7A细胞,同时使用嘌呤霉素对TRAF2低表达的MH7A稳转株进行筛选.使用CCK-8法、Western blot、qPCR检测MH7A中肿瘤坏死因子TNF-α诱导TRAF2低表达的MH7A增殖功能及下游信号TRAF2、P65蛋白表达和mRNA水平.结果 成功构建了 PLKO.1-TRAF2-shRNA(1)、PLKO.1-TRAF2-shRNA(2)和 PLKO.1-TRAF2-shRNA(3)慢病毒载体质粒和对照组慢病毒载体质粒PLKO.1-puro,将3个TRAF2-shRNA慢病毒载体质粒和对照组慢病毒载体质粒PLKO.1-puro分别与慢病毒包装质粒导入HEK 293T获得病毒液,将病毒液感染MH7A细胞后,经嘌呤霉素(2.00μg/ml)筛选,2 d得到MH7A稳转株;qPCR 和 Western blot 结果显示,PLKO.l-TRAF2-shRNA(1)MH7A细胞稳转株中TRAF2 mRNA和蛋白的表达较阴性对照组明显下降;CCK-8和Western blot结果表明,MH7A中TRAF2敲低后,TNF-α诱导的TRAF2低表达的MH7A细胞增殖和P65的磷酸化水平明显下降.结论 成功构建了 PL-KO.1-TRAF2-shRNA(1)MH7A 细胞稳转株,研究 TNF-α-TRAF2信号活化介导RA滑膜细胞异常增殖中的作用.
Objective To construct a stable synovial cell line MH7A from rheumatoid arthritis(RA)patients using lentiviral vectors that interfere with the expression of tumor necrosis factor receptor associated factor 2(TRAF2),and to study the role of TNF-α-TRAF2 signaling in MH7A abnormal proliferation.Methods Based on the design principles of human TRAF2 gene sequence and shRNA sequence,three pairs of TRAF2 shRNA interference se-quences were designed and synthesized.The primers were annealed by PCR,and a linear vector was obtained by double enzyme digestion PLKO.1-puro.The linearized vector was connected to the annealed primers through Solu-tion I,and the connected products were introduced into receptive cells.The plates were coated,and positive colo-nies were selected for sequencing.Three different recombinant plasmids of PLKO.1-TRAF2-shRNA lentivirus were constructed,and lentivirus packaging plasmids was used to package logarithmic growth phase HEK 293T cells.Vi-rus solution was collected to infect MH7A cells.At the same time,puromycin was used to screen MH7A stable transgenic strains with low TRAF2 expression.CCK-8 method,Western blot,and qPCR were used to detect the proliferation function of MH7A induced by TNF-α and low expression of TRAF2,as well as downstream signal TRAF2,P65 protein expression and mRNA levels.Results PLKO.1-TRAF2-shRNA(1),PLKO.1-TRAF2-shR-NA(2),and PLKO.1-TRAF2-shRNA(3)lentivirus vector plasmids and control group lentivirus vector plasmids PLKO.1-puro were successfully constructed.The three TRAF2-shRNA lentivirus vector plasmids and control group lentivirus vector plasmids PLKO.1-puro were respectively introduced into the lentivirus packaging plasmid of HEK 293T to obtain virus solution.After infecting MH7A cells with the virus solution,they were treated with puromycin(2.00 µ G/mL)screening and obtaining MH7A stable transgenic plants after 2 days.Through qPCR and Western blot results,it was found that the expression of TRAF2 mRNA and protein in PLKO.1-TRAF2-shRNA(1)MH7A stably transfected cells was significantly reduced compared to the negative control group.The results of CCK-8 and Western blot showed that after knocking down TRAF2 in MH7A,the proliferation of MH7A cells with low TRAF2 expression induced by TNF-α and the phosphorylation level of P65 were significantly reduced.Conclusion A sta-ble transgenic strain of PLKO.1-TRAF2-shRNA(1)MH7A cells was successfully constructed to investigate the role of TNF-α-TRAF2 signal activation in mediating abnormal proliferation of RA synovial cells.
陈露颖;蒋励萍;王伟康;左书俊;蒯佳婕;马旸;韩陈陈;魏伟
安徽医科大学临床药理研究所、抗炎免疫药物教育部重点实验室、抗炎免疫药物安徽省协同创新中心,合肥 230032
基础医学
类风湿关节炎MH7A肿瘤坏死因子受体相关因子2慢病毒载体
rheumatoid arthritisMH7Atumor necrosis factor receptor related factor 2lentivirus vector
《安徽医科大学学报》 2024 (002)
选择性TRAF2-TRADD结合阻断剂抑制类风湿关节炎滑膜细胞异常活化的分子机制
193-199 / 7
国家自然科学基金(编号:82104187、82173824、81973332);安徽省自然科学基金(编号:2108085QH382);中国博士后科学基金(编号:2021T140002、2021M700184);安徽省博士后基金(编号:2020B430)
评论